Research Finds Nerve Damage in Patients with Fibromyalgia
Objective skin test for small fiber neuropathy
NEW YORK, Dec. 16, 2014 /PRNewswire/ — Therapath, LLC (www.therapath.com), a leader in neuropathology laboratory services, reports that new findings have revealed that patients diagnosed with fibromyalgia may also have a diagnosable small fiber neuropathy. Recently, several studies have examined fibromyalgia patients for small fiber neuropathy using a skin biopsy test to determine Epidermal Nerve Fiber Density (ENFD). The studies reported a decrease in ENFD in a subset of patients with fibromyalgia (Oaklander et al., Pain 2013; Caro & Winter, Arthritis Rheumatology 2014; Giannoccaro et al., Muscle Nerve 2014). These studies conclude that ENFD testing should be considered in the diagnostic work-up of fibromyalgia to search for small fiber neuropathy.
www.therapath.com/rheumatology
Patients diagnosed with small fiber neuropathy exhibit similar symptoms to those with fibromyalgia, including:
- Chronic pain
- Increased sensitivity to pressure and touch
- Numbness and tingling
Epidermal Nerve Fiber Density (ENFD) is an objective measure of the small nerve fibers. To perform the test, a doctor performs a biopsy in the office to obtain a small piece of skin. That skin sample is then sent to a neuropathology laboratory for analysis. Patients with small fiber neuropathy exhibit a significant reduction in the ENFD. www.therapath.com/enfd
About Therapath Neuropathology:
Therapath Neuropathology, founded in 2004, is a College of American Pathology accredited (CAP) and CLIA licensed specialized laboratory. The medical team are board certified in neuropathology, academically trained and extensively published. Therapath’s focus is on research and development in the testing services for muscle biopsy, nerve biopsy with teased fiber analysis, ocular (including optic neuritis), skin epidermal nerve fiber density, sweat gland nerve fiber density, skin biopsy for CADASIL and other storage disorders as well as brain/spinal cord specimens. Therapath serves hospitals, private practitioners, reference laboratories, the pharmaceutical industry, and researchers throughout the United States and internationally.
Contact:
Therapath Neuropathology
Geoff Whitehouse, 800-681-4338
gwhitehouse@therapath.com
Related Articles
Research Finds Nerve Damage in Patients with Fibromyalgia
Becky Tsai2022-09-05T17:50:29-05:00
Therapath, LLC reports that new findings have revealed that patients diagnosed with fibromyalgia may also have a diagnosable small fiber neuropathy. [Read More]
Quality of Life and Usefulness of Skin Biopsy in Small Fiber Neuropathy (SFN)
Becky Tsai2022-09-05T17:51:25-05:00
Bakkers et al examined a total of 265 patients diagnosed with small fiber neuropathy (SFN). They found that SFN was associated with a severe impairment in Quality of Life...[Read More]
New Upper Extremity Standard Biopsy Sites for Diagnosis of Small Fiber Neuropathy
Becky Tsai2022-09-05T17:52:41-05:00
Therapath LLC has established normative values for two upper limb body sites that can now be used to evaluate 3mm punch skin biopsy specimens...[Read More]
United Healthcare Signs Therapath Neuropathology to National Agreement to Provide Specialty Neuropathology Services to United Healthcare Members
Becky Tsai2022-09-05T17:54:35-05:00
Therapath LLC, the leader in comprehensive diagnostic and consultative neuropathology laboratory services, has signed a national contract with United Healthcare...[Read More]
Research Finds Nerve Damage in Patients with Fibromyalgia
Objective skin test for small fiber neuropathy
NEW YORK, Dec. 16, 2014 /PRNewswire/ — Therapath, LLC (www.therapath.com), a leader in neuropathology laboratory services, reports that new findings have revealed that patients diagnosed with fibromyalgia may also have a diagnosable small fiber neuropathy. Recently, several studies have examined fibromyalgia patients for small fiber neuropathy using a skin biopsy test to determine Epidermal Nerve Fiber Density (ENFD). The studies reported a decrease in ENFD in a subset of patients with fibromyalgia (Oaklander et al., Pain 2013; Caro & Winter, Arthritis Rheumatology 2014; Giannoccaro et al., Muscle Nerve 2014). These studies conclude that ENFD testing should be considered in the diagnostic work-up of fibromyalgia to search for small fiber neuropathy.
www.therapath.com/rheumatology
Patients diagnosed with small fiber neuropathy exhibit similar symptoms to those with fibromyalgia, including:
- Chronic pain
- Increased sensitivity to pressure and touch
- Numbness and tingling
Epidermal Nerve Fiber Density (ENFD) is an objective measure of the small nerve fibers. To perform the test, a doctor performs a biopsy in the office to obtain a small piece of skin. That skin sample is then sent to a neuropathology laboratory for analysis. Patients with small fiber neuropathy exhibit a significant reduction in the ENFD. www.therapath.com/enfd
About Therapath Neuropathology:
Therapath Neuropathology, founded in 2004, is a College of American Pathology accredited (CAP) and CLIA licensed specialized laboratory. The medical team are board certified in neuropathology, academically trained and extensively published. Therapath’s focus is on research and development in the testing services for muscle biopsy, nerve biopsy with teased fiber analysis, ocular (including optic neuritis), skin epidermal nerve fiber density, sweat gland nerve fiber density, skin biopsy for CADASIL and other storage disorders as well as brain/spinal cord specimens. Therapath serves hospitals, private practitioners, reference laboratories, the pharmaceutical industry, and researchers throughout the United States and internationally.
Contact:
Therapath Neuropathology
Geoff Whitehouse, 800-681-4338
gwhitehouse@therapath.com
Related Articles
Research Finds Nerve Damage in Patients with Fibromyalgia
Becky Tsai2022-09-05T17:50:29-05:00
Therapath, LLC reports that new findings have revealed that patients diagnosed with fibromyalgia may also have a diagnosable small fiber neuropathy. [Read More]
Quality of Life and Usefulness of Skin Biopsy in Small Fiber Neuropathy (SFN)
Becky Tsai2022-09-05T17:51:25-05:00
Bakkers et al examined a total of 265 patients diagnosed with small fiber neuropathy (SFN). They found that SFN was associated with a severe impairment in Quality of Life...[Read More]
New Upper Extremity Standard Biopsy Sites for Diagnosis of Small Fiber Neuropathy
Becky Tsai2022-09-05T17:52:41-05:00
Therapath LLC has established normative values for two upper limb body sites that can now be used to evaluate 3mm punch skin biopsy specimens...[Read More]
United Healthcare Signs Therapath Neuropathology to National Agreement to Provide Specialty Neuropathology Services to United Healthcare Members
Becky Tsai2022-09-05T17:54:35-05:00
Therapath LLC, the leader in comprehensive diagnostic and consultative neuropathology laboratory services, has signed a national contract with United Healthcare...[Read More]
